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ABSTRACT 
 
Background: Cardiovascular disease (CVD) prevention guidelines are generally based on the absolute 
risk of a CVD event, but there is increasing interest in using 'heart age' to motivate lifestyle change 
when absolute risk is low. Previous studies have not compared heart age to 5-year absolute risk, or 
investigated the impact of younger heart age, graphical format and numeracy. 
Objective: Compare heart age versus 5-year absolute risk on psychological/behavioural outcomes.  
Design: 2 (heart age, absolute risk) x 3 (text only, bar graph, line graph) experiment. 
Setting: Online. 
Participants: 570 Australians aged 45-64 years, not taking CVD-related medication. 
Intervention: CVD risk assessment. 
Measurements: Intention to change lifestyle, recall, risk perception, emotional response, perceived 
credibility, lifestyle behaviours after 2 weeks. 
Results: Most participants had lifestyle risk factors (95%) but low 5-year absolute risk (94%). Heart 
age did not improve lifestyle intentions/behaviours compared to absolute risk, was more often 
interpreted as a higher risk category by low risk participants (47% vs 23%), and decreased perceived 
credibility and positive emotional response. Overall, correct recall dropped from 65% to 24% after 2 
weeks, with heart age recalled better than absolute risk at 2 weeks (32% vs 16%). These results were 
found across younger/older heart age result, graphical format and numeracy. 
Limitations: Communicating CVD risk in a consultation rather than online may produce different 
results. 
Conclusions: There is no evidence that heart age motivates lifestyle change more than 5-year 
absolute risk in individuals with low CVD risk. Five-year absolute risk may be a better way to explain 
CVD risk, since it is more credible, does not inflate risk perception, and is consistent with clinical 
guidelines that base lifestyle and medication recommendations on absolute risk.
4 
 
 
INTRODUCTION 
 
Clinical guidelines for cardiovascular disease (CVD) prevention generally base medication 
recommendations on the absolute risk of a CVD event rather than managing individual risk factors.1 
This is expressed as the short-term percentage risk of a cardiovascular event, usually over a 5 or 10 
year timeframe. However, adherence to these guidelines is suboptimal around the world,2 and 
clinicians report difficulties communicating absolute risk to patients.3 Research has established that 
percentages are poorly understood by both patients and clinicians.4, 5 Moreover, the absolute risk 
concept may also undermine lifestyle change messages for patients with low short-term CVD risk but 
elevated risk factors that increase their lifetime risk.6, 7 To address concerns that the absolute risk 
approach may miss opportunities to intervene before absolute risk becomes high, recent clinical 
guidelines in the UK advocate the use of 'heart age' to communicate lifetime risk and motivate 
prevention measures when absolute risk is still low.8 
 
Heart age is calculated by comparing an individual’s current absolute risk to the age at which they 
would reach that absolute risk if they had ‘ideal’ risk factors (e.g. non-smoker, systolic blood 
pressure 120 mmHg, total/HDL cholesterol ratio 4). 9 Older heart age than current age indicates 
elevated but modifiable risk, even if the short-term absolute risk of a CVD event is low (see Box 1). 
Younger heart age indicates that current risk factors are even lower than ‘ideal’ levels. The New 
Zealand Heart Foundation introduced an online calculator to promote the use of absolute risk 
guidelines in 2010 including both short-term (5-year) absolute risk and heart age in a line graph 
format, showing how CVD risk will increase over time if current risk factors remain the same 
compared to if they were ideal.9 A pre-post study suggested that this tool may increase clinician 
understanding and confidence regarding the use of absolute risk, but patient outcomes were not 
assessed.10 Recent clinical guidelines in the UK specifically advocate using heart age for lower risk 
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patients and even include medication recommendations based on heart age.8 The rationale for this 
change is that heart age reflects lifetime risk, and could potentially motivate patients with low short 
term risk to improve their lifestyle before their risk becomes high. However, there is little evidence 
that heart age is more effective than other risk formats, as previous studies have not directly 
compared it to 5 year absolute risk, and have not investigated the impact of being told younger 
compared to older heart age or graphical format.  
 
Qualitative studies suggest that patients may prefer heart age over other formats but raise concerns 
about its negative emotional impact. A focus group study using hypothetical risk found that patients 
liked heart age but were concerned it may frighten people if higher than their current age.11 A 'think 
aloud' study where patients used online CVD risk tools to calculate their actual heart age found that 
patients often misunderstand and discredit the results of heart age calculators, but they were 
prompted to consider lifestyle changes regardless of whether they believed the result or had a 
negative reaction to older heart age.12 Quantitative studies suggest that heart age may be effective 
for motivating lifestyle change and reducing CVD risk factors, but there is little direct evidence that it 
is more effective than alternative risk formats. An experimental study found that heart age improved 
understanding of risk compared to 10-year absolute risk and had more emotional impact for 
younger people at higher risk. Emotional impact also mediated the relationship between risk level 
and intention to change lifestyle for both formats.13 Comparison of heart age to 5-year absolute risk 
has not been addressed in previous studies, but a review of hypothetical absolute CVD risk formats 
suggests that shorter time frames (<10 years) may improve the accuracy of risk perception and 
increase intentions to change behaviour compared to longer time frames (10 years or more).14 
Clinical trials have found that risk communication including heart age, and the similar concept of 
lung age, can motivate behaviour change and improve risk factors, but these age-related formats 
were not directly compared to alternative risk formats.15, 16  
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There is no consensus on the ‘best’ way to present quantitative health risks in the broader risk 
communication literature, but the review of CVD risk formats mentioned above recommends 
graphical presentation.14  Best practice guidelines suggest that graphical formats have mixed effects 
compared to text-only presentations, and their benefit may depend on individual differences in 
numeracy and literacy.17, 18 However, there is some research to suggest that bar graphs and 
frequency-based icon arrays can be beneficial for understanding health risks, particularly for people 
with lower numeracy.19 This effect may be due to reducing various cognitive errors in the 
interpretations of textual expressions of risk, such as denominator neglect.18, 20 Since heart age is 
based on a comparison to ideal risk but does not directly relate to frequencies, bar graphs 
comparing actual versus ideal risk assessment results were used in this study, as an alternative to 
text only and line graph formats. 
 
Previous research has not investigated the effect of heart age compared to 5-year absolute risk, 
which is currently used in Australian and New Zealand guidelines, charts, and online tools.9, 21 Nor 
have there been any studies investigating the effect of communicating younger heart age, or 
presenting heart age in different graphical formats. This study aimed to address these gaps in the 
literature by experimentally testing the effect of heart age on psychological and behavioural 
outcomes compared to 5-year absolute risk in low (i.e., 5-year absolute risk of a CVD event <10%), to 
moderate risk (10-15% AR) patients, according to the Australian guidelines. 
 
METHOD 
 
Design 
 
A 2 x 3 factorial design was used to investigate the effect of CVD risk format (5-year absolute risk, 
heart age) and different graphical formats (text only, text + bar graph, text + line graph) on 
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psychological and behavioural outcomes. The full study protocol is provided in the supplementary 
material, including examples of all presented CVD risk formats. This paper focuses on the effect of 
heart age compared to 5-year absolute risk on the main outcomes of interest in previous heart age 
literature (recall, perceived risk category, emotional response, perceived credibility, intention to 
change lifestyle, and self-reported behaviour change). See Figure 1. Additional psychological 
outcomes were assessed to explore possible mechanisms for any effect of heart age on lifestyle 
intention (alternative risk perception measures: numerical risk, verbal risk, comparative risk, feeling 
of risk;22 and illness representation measures: worry about heart disease, perceived control and 
timeline of heart disease, subjective understanding of heart disease23, 24). However, since the 
hypothesised effect of heart age on lifestyle intentions was not found, main effects and interactions 
between risk and graphical formats for these additional outcomes are reported as exploratory 
analyses in the supplementary material.  
 
[INSERT FIGURE 1] 
 
Sample size 
 
The a priori sample size calculation indicated that 85 participants per group, totalling 510 
participants, would provide 90% power to detect a moderate effect size of d=0.5 (standardised 
difference) in the primary outcome of intention to change lifestyle as measured immediately post 
intervention, assuming a two-sided alpha of 0.05. We aimed to recruit 20% more cases to account 
for potential dropout at two week follow-up.                                                                                                                                           
 
Recruitment 
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 A national Australian sample was recruited through a market research company (SSI: Survey 
Sampling International) in 2014. Sampling quotas were set to ensure equal participant numbers by 
gender and 5 year age group, since these are important determinants of CVD risk and we aimed to 
recruit participants with both younger and older heart age results at a range of ages. The eligibility 
criteria were being aged 45-64 years, not currently taking blood pressure or cholesterol-lowering 
medication, non-diabetic, not already known to be at high risk of CVD based on criteria in the 
Australian guidelines, and being able to read health-related information in English without help most 
of the time. Participants were recruited via email or by visiting the SSI website independently. They 
received points for participating in the study, which they could redeem for entry into prize draws 
through SSI's online system.  
 
Materials 
 
Participants completed a CVD risk assessment based on Australian absolute risk guidelines and the 
New Zealand Heart Foundation’s approach to calculating heart age, using the 5-year Framingham 
risk equation9, 21, 25 and determining heart age by comparing a participant’s current absolute risk to 
the age at which they would reach that absolute risk if they had ‘ideal’ risk factors (i.e. non-smoker, 
systolic blood pressure 120 mmHg, total/HDL cholesterol ratio 4). If blood pressure or cholesterol 
were not known the average by age and gender was used based on data from non-diabetic 
participants who were not taking blood pressure or cholesterol-lowering medication in the AusDiab 
study: a longitudinal study of 11,000 people investigating diabetes prevalence in Australia.26 If 
participants indicated that a health professional had told them their blood pressure and/or 
cholesterol was raised, one standard deviation was added to the average for their age and gender. 
An example of the text for different risk formats is provided in Box 1, with additional examples in 
Box 2, and graphical presentation formats provided in the supplementary material. 
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Box 1. Example of randomised risk formats 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 50 year old male smoker with blood pressure = 130/80mmHg and cholesterol ratio = 4 would 
be compared to a 50 year old male with 'ideal' risk factors (non-smoker, blood pressure = 
120/80mmHg, cholesterol ratio = 4), and receive his results in one of the following formats, 
depending on which group he was randomised to (note: non-smokers did not receive 
information about quitting smoking; and heart age was set to a maximum of 74, in line with the 
Framingham model used in Australian guidelines and the New Zealand heart age tool). 
 
 Absolute risk group:  
“Your risk of having a heart attack or stroke in the next 5 years is 8%. If you stopped smoking and 
had lower blood pressure and cholesterol, your risk would be 3%. You can reduce your blood 
pressure and cholesterol by quitting smoking, improving your diet and increasing physical 
activity.” 
 
Heart age group:  
“Your heart age is 66, 16 years older than you. If you stopped smoking and had lower blood 
pressure and cholesterol, your heart age would be 50, the same as your current age. You can 
reduce your blood pressure and cholesterol by quitting smoking, improving your diet and 
increasing physical activity.”  
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Box 2. Example of text results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All participants received their results in text format, with the exact wording depending on their 
randomised risk format (percentage risk or heart age), whether their calculated heart age result 
was older, the same or younger than their current age, and whether they were a smoker or not. 
 
 Older heart age result than current age, percentage risk format, non-smoker:  
“Your risk of having a heart attack or stroke in the next 5 years is 5%. If you had lower blood 
pressure and cholesterol, your risk would be 2%. You can reduce your blood pressure and 
cholesterol by improving your diet and increasing physical activity.” 
 
Older heart age result than current age, percentage risk format, smoker:  
“Your risk of having a heart attack or stroke in the next 5 years is 17%. If you stopped smoking 
and had lower blood pressure and cholesterol, your risk would be 5%. You can reduce your blood 
pressure and cholesterol by quitting smoking, improving your diet and increasing physical 
activity.” 
 
Same heart age result as current age, heart age format:  
“Your heart age is 48, the same as your current age. Congratulations, this is the ideal result for 
your age and gender.” 
 
Younger heart age result than current age, heart age format: 
“Your heart age is 45, 3 years younger than you. Congratulations, this is even better than the 
ideal result for your age and gender.” 
 
 
11 
 
Outcome measures 
 
The question format and response options for all measures are provided in the supplementary 
material. Demographic, clinical and lifestyle risk factors were assessed pre-intervention. Numeracy 
was also assessed at this point using the validated Subjective Numeracy Scale.27 
 
Psychological measures were assessed immediately post-intervention: 
a) The primary outcome was intention to change lifestyle (improve diet, increase physical activity, 
stop smoking if applicable). This was assessed using a 3 item Likert scale from the Theory of Planned 
Behavior for each lifestyle aspect, a well-established approach in the behavioural science 
literature.28 For example, for physical activity, participants rated the following statements from 
1=strongly disagree to 7=strongly agree: I expect to do more physical activity in the next 2 weeks; I 
want to do more physical activity in the next 2 weeks; I intend to do more physical activity in the 
next 2 weeks. Average scores for each lifestyle aspect were calculated as well as the average across 
applicable lifestyle aspects (6 items for non-smokers, 9 items for smokers).28, 29 
b) Recall of heart age or absolute risk result was assessed as correct (i.e. the exact right answer) or 
incorrect based on open numerical responses (and re-assessed at 2-week follow-up).   
c) Risk perception was assessed as the perceived risk category that the result indicated. In line with 
the Australian guidelines, low was defined as a 5-year absolute risk of a CVD event <10%, moderate 
is 10-15% and high >15% AR. These categories were not defined for participants in the study 
materials, as we were interested in the participants’ own impressions of their risk level, not their 
understanding of the categories as defined by the Australian guidelines.  
d) Emotional response was assessed using a 6 item Likert scale (from 0=”none of this feeling” to 
10=”a lot of this feeling”), with positive (hopeful, optimistic, enthusiastic; α=.81) and negative 
(afraid, anxious, worried; α=.85) subscales scored based on the average of the relevant items, used 
in previous research on the role of affect in health risk information seeking.30 
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e) Perceived credibility was assessed with a 4 item Likert scale (from 1=”completely disagree” to 
7=”completely agree”) scored as the average of the items (I felt that the numbers received were ‘‘my 
numbers"; I found the results to be written personally for me; I felt that the information was 
relevant to me; I felt that the information was designed specifically for me; α=.89), used in previous 
research on the personal relevance and believability of online health risk assessments.31 
 
Behavioural/lifestyle measures were assessed pre- and post-intervention, and at 2 week follow-up: 
f) Information seeking was assessed by providing three links in randomised order at the end of the 
post-intervention questionnaire. Clicking on either of the two CVD-related links (to information 
about CVD risk and lifestyle on the Australian Heart Foundation website) was coded as a positive 
response; clicking on a link to Google or closing the browser was coded as a negative response, in 
line with the methods used in previous studies investigating online risk information seeking.32 
g) Intention to see a GP was assessed post-intervention using a 3 item Likert scale for intention as 
per the primary outcome, based on the average rating for the following statements from 1=strongly 
disagree to 7=strongly agree: I expect to discuss my risk of heart disease with a doctor in the next 2 
weeks; I want to discuss my risk of heart disease with a doctor in the next 2 weeks; I intend to 
discuss my risk of heart disease with a doctor in the next 2 weeks.29 Participants also reported 
whether they had seen or made an appointment to see their GP at 2 week follow-up (response 
options: yes or no). 
h) Smoking status was assessed pre-intervention and at 2 week follow-up with the question "Do you 
currently smoke cigarettes?" (response options: yes or no). 
i) Physical activity was assessed pre-intervention and at 2 week follow-up using the 2Q-PA scale for 
moderate and vigorous physical activity, with a time scale of "in the last week" added. Adequate 
physical activity was defined as ≥3 vigorous sessions/week, or ≥5 moderate sessions/week, or 1-2 
vigorous sessions/week plus 3-4 moderate sessions/week.33 
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j) Diet was assessed pre-intervention and at 2 week follow-up using questions from a previous study 
on fruit and vegetable intake, modified to be consistent with Australian guidelines and the physical 
activity response options. Adequate diet was defined as having at least 2 servings of fruit and 5 
servings of vegetables per day in the last week. 34 
k) Body mass index was calculated using self-reported height and weight measures pre-intervention 
with options to provide this in either metric or imperial units. Clinically impossible values were 
recorded as missing. 
 
Analysis 
 
Continuous variables were described as mean (SD), or median (IQR: interquartile range) if the 
distributions were asymmetric. Categorical variables were summarised with percentages. The Mann-
Whitney test (non-parametric) was used to compare groups across continuous outcomes, and the 
Chi-square test was applied to categorical outcomes. We further explored the dependence of the 
results on participants’ calculated heart age result (younger/same versus older than current age) and 
numeracy by testing an interaction using logistic and quantile (for the median) regressions for 
categorical and continuous outcomes, respectively. Finally, we compared the differences between 
the group arms for the primary outcomes, adjusted for characteristics that were slightly unbalanced 
across the groups after randomisation, namely, gender, BMI, blood pressure assessed in the last year 
and having been told the cholesterol was high. For the categorical outcomes we performed the 
adjustment using logistic or multinomial regression and for the continuous outcomes we used 
quantile regressions. 
The significance level for all tests was set at 0.05. 
 
 
RESULTS 
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Participants were recruited via email or by visiting the SSI website independently, and quotas were 
set to achieve equal participant numbers in each age/gender category, so an exact response rate 
cannot be calculated. Of 3027 people who accessed the website during the recruitment period 141 
did not consent to participate, 498 did not meet the eligibility criteria, and 1783 did not complete 
the questionnaire before their age/gender quota was full and their eligibility data were not 
recorded. Recruitment was closed after 605 participants had been randomised and completed the 
whole questionnaire. Of these 605 participants 35 were excluded from the analyses because they 
specified their blood pressure and/or cholesterol values as zero, which meant the Framingham risk 
equation could not be calculated and they could not be shown their allocated CVD risk format. The 
remaining 570 participants were included in the analysis for post-intervention outcomes, of which 
469 participants (82%) completed the follow-up questionnaire for 2 week outcomes. See Figure 1. 
Baseline characteristics and calculated risk results for those included in the post-intervention 
analyses are displayed in Table 1; psychological and behavioural outcomes are displayed in Table 2 
and Figures 2 and 3. 
 
Participant characteristics 
 
The randomised groups were similar in terms of CVD risk factors with most participants having 
lifestyle risk factors (95% had inadequate physical activity, inadequate diet, higher than normal body 
mass index and/or were current smokers) but low short-term absolute risk of a CVD event (94% had 
5 year absolute risk <10%). Calculated heart age was on average 3 years older than current age (57 
versus 54 years) with 63% of participants across randomised groups having a higher heart age than 
current age, 1% having the same heart age as their current age, and 36% having a lower heart age 
than current age. 
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Primary outcome 
 
For intention to change lifestyle (diet, physical activity, smoking, and the average of these), there 
were no significant differences between the absolute risk and heart age groups (see Table 2). There 
were no significant interactions with numeracy, i.e., there was no evidence that differences between 
the groups were affected by participants' numeracy. These results did not change after adjustment 
for gender, BMI, blood pressure assessed in the last year or having been told the cholesterol was 
high. 
 
Secondary outcomes 
 
Several differences between the absolute risk and heart age groups were found for secondary 
outcomes, and there were additional subgroup differences when participants with a younger/same 
calculated heart age were analysed separately from participants with an older calculated heart age.  
 
Recall 
 
The majority of participants (65%) correctly recalled their risk result immediately post-intervention, 
but this dropped to 24% after 2 weeks. Participants in the heart age group were more likely to 
correctly recall their risk result after 2 weeks compared to those in the absolute risk group across 
younger and older heart age results (32% versus 16%; p<0.001;). For participants with a younger or 
same calculated heart age compared to current age, those who received their result in heart age 
format were more likely to correctly recall their result post-intervention compared to those who 
received an absolute risk format (80% versus 63%, p=0.009). The risk format did not make a 
difference in post-intervention recall amongst participants with a higher calculated heart age (61% 
for both formats, p>0.999). As a sensitivity analysis we tested whether there was any impact on the 
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recall results when a recalling margin of error was allowed for (ranging from 0.05-0.2 standard 
deviations).  The results were similar, with recall better in the heart age condition.  In fact the heart 
age format was further favoured since the error was much smaller in the heart age condition. 
 
Risk perception 
 
Most participants (94%) were in the low risk category according to Australian guidelines (5-year 
absolute risk of a CVD event <10%),21 but only 53% of participants in the heart age group perceived 
the result as indicating low risk of having a heart attack or stroke compared to 77% in the absolute 
risk group (p<0.001). Of the 94% low risk participants who received their risk result in absolute risk 
format (n=266), 78% perceived their result to be indicating low risk, 20% perceived it to be moderate 
risk, and 2% perceived it to be high risk. Of the low risk participants who received their risk result in 
heart age format (n=269) 56% perceived their result to be indicating low risk, 40% perceived it to be 
moderate risk, and 4% perceived it to be high risk (see Figure 2). For those with moderate/high risk 
the effect of heart age is unclear.  There were no significant differences between risk perception and 
actual risk by format (p=0.071), however, the small number of cases (with only 1 high risk participant 
who was randomized to the absolute risk arm) limit the conclusions for this group. 
 
Emotional response 
 
Participants in the heart age group had a less positive emotional response (hopeful, optimistic, 
enthusiastic) to the risk result compared to participants in the absolute risk group (median 5.0 
versus 6.0; p<0.001). Heart age also increased negative emotional response (afraid, anxious, 
worried) compared to absolute risk, but this difference was not statistically significant (median 3.0 
versus 2.3; p=0.40; see Figure 3) . 
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Perceived credibility 
 
Perceived credibility of the risk result (i.e. whether the results were believed/personally relevant) 
was lower for participants in the heart age group compared to participants in the absolute risk group 
(median 4.8 versus 4.3; p<0.001; see Figure 3). 
 
Behavioural outcomes 
 
No risk format effects were found for behavioural outcomes immediately post-intervention 
(intention to see a GP, information seeking behaviour) or at 2 week follow-up (percentage adequate 
diet, adequate physical activity, smokers, GP appointment for CVD risk assessment). 
 
[INSERT TABLES 1-2 AND FIGURES 2-3] 
 
DISCUSSION 
 
The results of this study indicate that online assessment of heart age is no more effective than 5-
year absolute risk for increasing lifestyle change intentions and behaviour, in a general population 
sample with lifestyle risk factors but mostly low short-term risk of a CVD event (mean 5-year 
absolute risk <5% in both groups). The sample size was sufficient to assess this as the primary 
outcome, so the result is unlikely to be due to a lack of power, and the sample characteristics 
reflected the target group for heart age communication in recent clinical guidelines advocating the 
use of heart age.8 Compared to 5-year absolute risk, heart age was more likely to be interpreted as 
moderate/high risk by low risk participants, decreased positive emotional response to the results, 
and decreased the perceived credibility of the risk assessment; however, heart age was more likely 
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to be accurately recalled after 2 weeks. These effects were found across younger and older heart age 
results and numeracy.  
 
Our findings are in line with a recent experimental study that found adding heart age to salient 
absolute risk formats had no effect on lifestyle intentions35 and contradict suggestions that it is more 
motivating than absolute risk in individuals with low CVD risk.8, 9, 13 Five-year absolute risk is by 
definition a smaller number than 10-year absolute risk, and people have a tendency to ignore the 
base rate for probabilistic information, including the time frame of health statistics.36 Moreover, 
people are so familiar with their own age that it stands as an available benchmark to compare heart 
age to. Theoretically, heart age could therefore be expected to have even more impact compared to 
5-year rather than 10-year absolute risk, since the number indicating ‘risk’ is smaller when a 5-year 
time frame is used. However, our findings suggest that the prospect of a CVD event in the short-term 
has as much impact on lifestyle intention as the heart age format.  This is supported by a previous 
review of absolute CVD risk formats that found shorter time frames (<10 years) increase intentions 
to change behaviour compared to longer time frames (10 years or more) in hypothetical studies.14 
The issue of low credibility identified in our previous qualitative study of online heart age calculators 
was also confirmed in this study: patients discredit the results of online heart age calculators, and 
perceive heart age as less credible than absolute risk.12 The finding that heart age has more 
emotional impact and is more memorable than absolute risk supports previous quantitative and 
qualitative studies,11-13 but this did not translate into greater intentions to change lifestyle. This is in 
contrast to a recent Spanish trial (published after this study was conducted) that found greater 
reductions in lifestyle and clinical risk factors for CVD after 12 months when patients were shown an 
interactive heart age tool by their clinician compared to usual care or communicating 10-year 
absolute risk in verbal format.37 The discrepancy between these findings may be explained by the 
presentation formats used: the heart age group in the Spanish trial viewed an interactive, computer-
based heart age tool demonstrating the effect of risk factor modification during a clinical 
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consultation as well as the verbal format that the absolute risk group received (personal 
communication with corresponding author), so the effect may be attributed to a more compelling 
visual format rather than heart age per se. In the current study, the heart age and absolute risk 
groups viewed equivalent verbal and visual formats to enable a direct comparison (see 
supplementary material). Alternatively, 5-year absolute risk and heart age may both be superior to 
10-year absolute risk, but no different from each other, in terms of motivation to change lifestyle. 
The lack of impact of numeracy in this study contributes to the mixed findings in the broader risk 
communication literature.18  
 
The main clinical implication of this study is that advocating heart age as a more effective risk 
communication format than absolute risk may be premature. Providing a 5-year absolute risk format 
may be a better way to explain risk to patients, since it is more credible, does not artificially inflate 
risk perception, and is consistent with clinical guidelines that base lifestyle and medication 
recommendations on absolute risk thresholds.1 On the other hand, heart age is recalled better, and 
assessment by a clinician may ameliorate the reduced credibility for heart age when provided via an 
online calculator. Assessment of heart age in a clinical consultation could also provide an 
opportunity to correct inaccurate risk perception and clearly explain the difference between short 
term risk (e.g. 5-year risk of a CVD event) and lifetime risk (reflected by the heart age concept). An 
additional benefit could be improved use of the absolute risk guidelines by GPs, if communicating 
heart age rather than absolute risk drives greater confidence in using the guidelines.10 Although 
these guidelines are targeted at clinicians, the online CVD risk and heart age calculators that support 
them are publicly available (www.jbs3risk.com; www.knowyournumbers.co.nz). Such health risk 
calculators are widely available online and used by consumers without clinician involvement,38 so 
effective CVD risk communication formats for both clinical and online settings are needed. 
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The strengths of this study include a rigorous experimental design specifically testing heart age alone 
against 5-year absolute risk alone using equivalent verbal and visual formats, inclusion of a follow-up 
time point to assess behaviour change as well as psychological outcomes, and a national sample in 
the target group for heart age communication (i.e. lifestyle risk factors but low short-term risk of a 
CVD event). The limitations include the use of a static online format, which may not be as impactful 
as an interactive website or clinician communication during a consultation, the use of information 
seeking behaviour as a proxy for actual behaviour, the fact that we only included computer-literate 
participants and self-reported outcomes, and the need to exclude some participants due to 
inaccurate self-reported risk factor data. 
 
The findings of this study could be extended by comparing the effect of communicating heart age 
versus 5-year absolute risk in clinical consultations using equivalent verbal and visual formats. 
Clinician involvement in communicating heart age may prevent the reduction in credibility and 
inaccurate risk perception found in this study, and exploratory analyses of risk and illness 
perceptions suggest that heart age may be useful in specific situations (see supplementary material). 
Further research is required to better understand the impact of the different formats on participants 
at moderate and high CVD risk since the majority of participants in this study were at low risk.  
Research should also confirm whether: 1) communicating text-based heart age or adding a bar graph 
to absolute risk is beneficial when GPs want to increase risk and illness perceptions for patients with 
low short-term absolute risk but lifestyle risk factors; 2) communicating younger heart age is 
beneficial for reducing risk perceptions amongst anxious low risk patients, without demotivating 
good lifestyle behaviours; and 3) our findings hold when using different time horizons. Alternative 
ways to explain the difference between short-term and lifetime risk, and the relationship between 
heart age and absolute risk, could also be explored. Since the benefits of lifestyle are not restricted 
to CVD, less specific age-related formats such as ‘biological age’ or ‘real age’ may also be helpful for 
motivating lifestyle change without inflating CVD risk perception. 
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This study found that heart age was more memorable and had more emotional impact than 5-year 
absolute risk, but there was no benefit with respect to changing lifestyle intentions or behaviour. 
Communicating 5-year absolute risk may be the better approach, since it is more credible, avoids 
inflating risk perception, and is consistent with clinical guidelines that base lifestyle and medication 
recommendations on absolute risk thresholds.
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Table 1. Participant characteristics and risk results by randomised risk format (n= 570) 
 Absolute risk 
(n=281) 
 Heart age 
(n=289) 
Demographic risk factors    
Age, mean (SD) 54 (6)  54 (6) 
Male, n (%) 134 (48)  153 (53) 
Aboriginal or Torres Strait Islander, n (%) 3 (1)  4 (1) 
Numeracy, median  (IQR)  4.3 
(3.4-5.0) 
 4.4 
(3.6-5.0) 
Lifestyle risk factors  
 
 
Body mass index (pre-intervention), n (%)  
 
 
Underweight 10 (4) 
 
12 (4) 
Normal 95 (34) 
 
106 (37) 
Overweight 92 (33) 
 
99 (34) 
Obese 81 (29) 
 
70 (25) 
Smoker (pre-intervention), n (%) 69 (25) 
 
72 (25) 
Cigarettes per day (pre-intervention), median (IQR) 15  
(10 - 20) 
 15 
(10 - 25) 
Adequate diet* (pre-intervention), n (%) 50 (18) 
 
51 (18) 
Adequate physical activity† (pre-intervention), n (%) 124 (44) 
 
128 (44) 
Clinical risk factors    
BP assessed in last year, n (%) 207 (74)  197 (68) 
Told BP raised by health professional, n (%) 45 (16)  42 (15) 
Cholesterol assessed in last year, n (%) 144 (51)  142 (49) 
Told cholesterol raised by health professional, n (%) 44 (16)  61 (21) 
Systolic BP (value/estimate), mean (SD) 122 (11)  121 (9) 
Cholesterol ratio (value/estimate), mean (SD) 3.8 (0.7)  3.8 (0.7) 
Calculated risk results    
5-year absolute CVD risk, mean (SD) 4.3 (3.1)  4.3 (3.0) 
5-year absolute CVD risk category, n (%)    
Low risk (<10%) 266 (95)  269 (93) 
Moderate risk (10-15%) 14 (5)  20 (7) 
High risk (>15%) 1 (0)  0 (0) 
Heart age, mean (SD) 57 (11)  57 (10) 
Lower heart age than current age, n (%) 107 (38)  100 (35) 
Same heart age as current age, n (%) 3 (1)  4 (1) 
Higher heart age than current age, n (%) 171 (61)  185 (64) 
*≥2 servings of fruit and ≥5 servings of vegetable per day, in the last week; †≥3 vigorous sessions, or ≥5 moderate 
sessions, or 1-2 vigorous sessions plus 3-4 moderate sessions, in the last week  
IQR: interquartile range; BP: blood pressure; CVD: cardiovascular disease 
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Table 2. Psychological and behavioural outcomes by randomised risk format 
 Absolute 
risk 
(n=281) 
Heart age 
(n=289) 
 
p-value 
Intention outcomes (post-intervention)  
 
 
  
To reduce smoking*, median (IQR) 
4.7  
(3.7 - 6.0) 
 5.0 
(4.0 - 5.7) 
 0.67** 
To improve diet*, median (IQR) 
4.3 
(3.0 - 5.7) 
 4.0 
(3.0 - 5.0) 
 0.47** 
To improve physical activity*, median (IQR) 
4.3  
(3.5 - 5.7) 
 4.3 
(3.7 - 5.3) 
 0.72** 
To improve diet/PA or diet/PA/smoking†, median (IQR) 
4.3  
(3.5 - 5.5) 
 4.4 
(3.5 - 5.2) 
 0.72** 
To see GP for CVD risk assessment*, median (IQR) 
2.0  
(1.0 - 3.0) 
 2.0 
(1.0 - 3.3) 
 0.35** 
Psychological outcomes  
 
 
  
Risk perception (post-intervention)      
Results indicate low risk of heart attack/stroke, n (%) 216 (77)  154 (53)   
Results indicate moderate risk of heart attack/stroke, n (%) 60 (21)  121 (42)  <0.001†† 
Results indicate high risk of heart attack/stroke, n (%) 5 (2)  14 (5)   
Correct recall (post-intervention), n (%) 173 (62)  195 (67)  0.17†† 
Correct recall (after 2 weeks), n (%) 37 (16)  77 (32)  <0.001†† 
Perceived credibility of results‡ (post-intervention), median (IQR) 
4.8  
(4.0 - 6.0) 
 4.3 
(3.3 - 5.3) 
 <0.001** 
Positive emotional response§ (post-intervention), median (IQR) 
6.0  
(5.0 - 8.0) 
 5.0 
(4.0 - 7.0) 
 <0.001** 
Negative emotional response§ (post-intervention), median (IQR) 
2.3  
(1.0 - 4.7) 
 3.0 
(1.0 - 5.0) 
 0.40** 
Behavioural outcomes 
 
 
 
  
Information seeking (post-intervention), n (%) 19 (7)  15 (5) 
 
0.43†† 
Smoker (after 2 weeks), n (%) 58(25)  55 (23)  0.62†† 
Cigarettes per day (after 2 weeks), median (IQR) 
12 
(6 - 20) 
 10 
(3 - 20) 
 0.72** 
Adequate diet|| (after 2 weeks), n (%) 27 (12)  22 (9)  0.45†† 
Adequate physical activity¶ (after 2 weeks), n (%) 91 (40)  100 (42)  0.74†† 
Made GP appointment (after 2 weeks), n (%) 23 (10)  27 (11)  0.78†† 
 
* Average of 3 items on 1-7 Likert scale (1=strongly disagree, 7=strongly agree); †Average of 6/9 items on 1-7 Likert 
scale depending on smoking status (1=strongly disagree, 7=strongly agree); ‡Average of 4 items on 1-7 Likert scale 
(1=strongly disagree, 7=strongly agree); §Average of 3 items on 0-10 Likert scale (0=none of this feeling, 10=a lot of 
this feeling); ||≥2 servings of fruit and ≥5 servings of vegetable per day in the last week; ¶≥3 vigorous sessions, or ≥5 
moderate sessions, or 1-2 vigorous sessions plus 3-4 moderate sessions, in the last week; higher scores indicate 
more of attribute. 
** Mann-Whitney test, ††Chi-square test  
IQR: Interquartile range; PA: physical activity; GP: general practitioner; CVD: cardiovascular disease. 
